Showing results (131-140 of 396) with videos related to

Sort By:
Pageof 40
Leukemia|February 3, 2007
Sequence-dependent synergy of the proteasome inhibitor bortezomib and cytarabine in mantle cell lymphomaO Weigert, A Pastore, M Rieken, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1992
Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulinsG Behre, I Schedel, B Nentwig, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1995
Bcl-2 protein expression in breast cancer in relation to established prognostic factors and other clinicopathological variablesC Binder, D Marx, R Overhoff, et al.
Der Internist|June 19, 2009
[Severe microcytic anemia with megaloblastic changes in the bone marrow. A hematological paradoxon?]R Reibke, A Hausmann, J Cnossen, et al.
Cancer Genetics and Cytogenetics|June 16, 2001
Gain of an isochromosome 5p: a new recurrent chromosome abnormality in acute monoblastic leukemiaC Schoch, S Bursch, W Kern, et al.
Deutsche Medizinische Wochenschrift (1946)|October 17, 2001
[Allogeneic transplantation in malignant lymphoma]O J Stötzer, M Schleuning, G Ledderose, et al.
Blood|July 15, 1994
Characterization of clone-specific rearrangement T-cell receptor gamma-chain genes in lymphomas and leukemias by the polymerase chain reaction and DNA sequencingM Kneba, I Bolz, B Linke, et al.
Leukemia|March 1, 1990
Definition of refractoriness against conventional chemotherapy in acute myeloid leukemia: a proposal based on the results of retreatment by thioguanine, cytosine arabinoside, and daunorubicin (TAD 9) in 150 patients with relapse after standardized first line therapyW Hiddemann, W R Martin, C M Sauerland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2011
The role of relatives in decisions concerning life-prolonging treatment in patients with end-stage malignant disorders: informants, advocates or surrogate decision-makers?D Hauke, S Reiter-Theil, E Hoster, et al.
Onkologie|February 1, 1990
Interventional antimicrobial strategy in febrile neutropenic patients. Results of a multicenter study in 1,260 patients with hematological malignancies. The Interventional Antimicrobial Strategy Study Group, Paul Ehrlich Society for ChemotherapyG Maschmeyer, H Link, W Hiddemann, et al.
Pageof 40